Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Mach

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
International Journal of Cancer|April 1, 2004
Highly efficient DNA incorporation of intratumourally injected [125I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenograftsFranz Buchegger, Florence Adamer, Andreas Oliver Schaffland, et al.
Clinical & Developmental Immunology|December 28, 2013
Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patientsFranz Buchegger, Steven M Larson, Jean-Pierre Mach, et al.
Journal for Immunotherapy of Cancer|September 27, 2018
Correction to: CART cells are prone to Fas- and DR5-mediated cell deathBenjamin O Tschumi, Nina Dumauthioz, Bastien Marti, et al.
Journal for Immunotherapy of Cancer|July 15, 2018
CART cells are prone to Fas- and DR5-mediated cell deathBenjamin O Tschumi, Nina Dumauthioz, Bastien Marti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomasChristel Larbouret, Bruno Robert, Isabelle Navarro-Teulon, et al.
International Journal of Cancer|July 22, 2006
Peptabody-EGF: a novel apoptosis inducer targeting ErbB1 receptor overexpressing cancer cellsOmar M Fattah, Sylvain M Cloutier, Christoph Kündig, et al.
International Immunopharmacology|November 9, 2005
A fetal sheep liver extract containing immunostimulatory substances including LPS acts as leukocyte activator in cells of LPS responder and non responder miceSilke Müller, Petra Hoffmann, Ulrich V D Esche, et al.
The Journal of Clinical Investigation|February 9, 2008
Sustained activation and tumor targeting of NKT cells using a CD1d-anti-HER2-scFv fusion protein induce antitumor effects in miceKathrin Stirnemann, Jackeline F Romero, Lucia Baldi, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|February 3, 2007
Biophysical characterization of the interaction of endotoxins with hemoglobinsJörg Howe, Malte Hammer, Christian Alexander, et al.
The Pharmacogenomics Journal|January 6, 2018
Analysis of cytokine immune response profile in response to inflammatory stimuli in mice with genetic defects in fetal and adult hemoglobin chain expressionIsmat Khatri, Christian Alexander, Klaus Brandenburg, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
International Journal of Cancer|April 1, 2004
Highly efficient DNA incorporation of intratumourally injected [125I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenograftsFranz Buchegger, Florence Adamer, Andreas Oliver Schaffland, et al.
Clinical & Developmental Immunology|December 28, 2013
Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patientsFranz Buchegger, Steven M Larson, Jean-Pierre Mach, et al.
Journal for Immunotherapy of Cancer|September 27, 2018
Correction to: CART cells are prone to Fas- and DR5-mediated cell deathBenjamin O Tschumi, Nina Dumauthioz, Bastien Marti, et al.
Journal for Immunotherapy of Cancer|July 15, 2018
CART cells are prone to Fas- and DR5-mediated cell deathBenjamin O Tschumi, Nina Dumauthioz, Bastien Marti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomasChristel Larbouret, Bruno Robert, Isabelle Navarro-Teulon, et al.
International Journal of Cancer|July 22, 2006
Peptabody-EGF: a novel apoptosis inducer targeting ErbB1 receptor overexpressing cancer cellsOmar M Fattah, Sylvain M Cloutier, Christoph Kündig, et al.
International Immunopharmacology|November 9, 2005
A fetal sheep liver extract containing immunostimulatory substances including LPS acts as leukocyte activator in cells of LPS responder and non responder miceSilke Müller, Petra Hoffmann, Ulrich V D Esche, et al.
The Journal of Clinical Investigation|February 9, 2008
Sustained activation and tumor targeting of NKT cells using a CD1d-anti-HER2-scFv fusion protein induce antitumor effects in miceKathrin Stirnemann, Jackeline F Romero, Lucia Baldi, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|February 3, 2007
Biophysical characterization of the interaction of endotoxins with hemoglobinsJörg Howe, Malte Hammer, Christian Alexander, et al.
The Pharmacogenomics Journal|January 6, 2018
Analysis of cytokine immune response profile in response to inflammatory stimuli in mice with genetic defects in fetal and adult hemoglobin chain expressionIsmat Khatri, Christian Alexander, Klaus Brandenburg, et al.
Pageof 3